This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity
Cell Death & Disease Open Access 07 November 2019
-
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells
Scientific Reports Open Access 16 April 2018
-
RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway
BMC Cancer Open Access 14 June 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Issaeva, N. et al. Nat. Med. 10, 1321–1328 (2004).
Stockman, B.J. & Dalvit, C. Prog. NMR Spectrosc. 41, 187–231 (2002).
Lepre, C.A., Moore, J.M. & Peng, J.W. Chem. Rev. 104, 3641–3675 (2004).
Bell, S., Klein, C., Müller, L., Hansen, S. & Buchner, J. J. Mol. Biol. 322, 917–927 (2002).
Ayed, A. et al. Nat. Struct. Biol. 8, 756–760 (2001).
Lee, H. et al. J. Biol. Chem. 275, 29426–29432 (2000).
Kussie, P.H. et al. Science 274, 948–953 (1996).
Picksley, S.M., Vojtesek, B., Sparks, A. & Lane, D.P. Oncogene 9, 2523–2529 (1994).
D'Silva, L. et al. J. am. Chem. Soc. 127, 13220–13226 (2005)
Vassilev, L.T. et al. Science 303, 844–848 (2004).
Author information
Authors and Affiliations
Supplementary information
Supplementary Fig. 1
HSQC spectra of the 15N labeled MDM2 (residues 1-118). (PDF 87 kb)
Supplementary Fig. 2
HSQC spectra of the 15N labeled MDM2 (residues 1-118). (PDF 104 kb)
Supplementary Fig. 3
Superposition of HSQC spectra of 15N labeled p53 in 5% DMSO (red) and after addition of RITA (blue). (PDF 135 kb)
Rights and permissions
About this article
Cite this article
Krajewski, M., Ozdowy, P., D'Silva, L. et al. NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro. Nat Med 11, 1135–1136 (2005). https://doi.org/10.1038/nm1105-1135
Issue Date:
DOI: https://doi.org/10.1038/nm1105-1135
This article is cited by
-
Anticancer strategies by upregulating p53 through inhibition of its ubiquitination by MDM2
Medicinal Chemistry Research (2020)
-
RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity
Cell Death & Disease (2019)
-
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells
Scientific Reports (2018)
-
CRISPR-Cas9–based target validation for p53-reactivating model compounds
Nature Chemical Biology (2016)
-
RITA (Reactivating p53 and Inducing Tumor Apoptosis) is efficient against TP53 abnormal myeloma cells independently of the p53 pathway
BMC Cancer (2014)